CTRS, Cell Therapies Research & Services is an independent French pharmaceutical company* with a strong and growing international presence. The company’s head office is located in Boulogne-Billancourt, in the western suburbs of Paris (France).
*with exclusively private capital
Since our creation in 2002, our ambition has been to develop and commercialize treatments for patients with strong therapeutic needs. We are committed to improving the quality of life of patients and are particularly involved in:
Creation of Laboratoires CTRS
2002
Partnership with AP-HP for the development of cholic acid
2007
European MA for Orphacol®
2013
Galien and Prescrire’s Gold Pill awards for Orphacol®
Firm honored with Prescrire’s information awards
2014
Galien International Award for Orphacol®
MA for Neofordex®
Firm honored with Prescrire’s information awards
2016
DCP in 12 countries for the Dexliq® MA
2018
« Because every patient has the right to expect treatment »
CTRS has always worked together with public bodies. In more than 15 years, our numerous partnerships have made it possible to offer patients the most appropriate diagnostic and therapeutic solutions for their needs. Because we all have the same ambition to progress in the field of health, we are convinced that it is by pooling our skills that we will be able to develop new therapeutic solutions for patients.
Our values
